(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...

Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s ...

Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2026 ...

Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...

The best ways to get rid of phlegm, from using nasal sprays to taking the right OTC medications. Plus, they explain what ...

A 2026 informational report on the Herz P1 Smart Oximeter fingertip pulse oxygen monitor, covering the company's FDA 510(k) cleared positioning, ±2% SpO2 blood oxygen accuracy specifications, smart ...

AeroDel’s founders, Zahir Jaffer, Shradha Sangwai and K.K.Suraj Rajan, have one common denominator: asthma. This led them to ...

UK government drives forward its 150-day clinical trial target: United Kingdom Friday, April 17, 2026, 09:00 Hrs [IST] NHS patients will be able to access life-changing new treatm ...

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduce ...

Patients at high risk for pulmonary complications had similar support needs at 90 days with HFNOT or standard oxygen.

After Asha Bhosle’s death from chest infection, doctors explain symptoms, warning signs, stages and treatment, especially ...